VYNE Therapeutics Inc. Gains 25.28%

Wed, Apr 26, 2023 at 07:07 PM

VYNE Therapeutics Inc. (VYNE:NASDAQ) rocketted at $5.6, a gain of 25.3%. On Wed, Apr 26, 2023, VYNE:NASDAQ hit a New 2-Week High of $5.6. The stock got featured on our News Catalysts scanner on Wed, Apr 19, 2023 at 09:06 AM in the 'BIOTECH' category. From Wed, Apr 12, 2023, the stock recorded 70.00% Up Days and 81.82% Green Days

The stock spiked on Tue, Jan 10, 2023 at $6.88 with a volume of 1M+.

About VYNE Therapeutics Inc. (VYNE:NASDAQ)

VYNE Therapeutics Inc is a biopharmaceutical company which focuses on the development and commercialization of variety of solutions using its proprietary Molecule Stabilizing Technology.

Top 10 Gainers:

Elevation Oncology Inc. (ELEV:NASDAQ), 77.19%
Etao International Co. Ltd. (ETAO:NASDAQ), 57.33%
SAI.TECH Global Corp Cl A Ord (SAI:NASDAQ), 34.05%
Euda Health Holdings Ltd Ord Shs (EUDA:NASDAQ), 34.01%
Panbela Therapeutics Inc. (PBLA:NASDAQ), 33.33%
Intuitive Machs Inc Cl A (LUNR:NASDAQ), 32.28%
Beasley Broadcast Group, Inc. (BBGI:NASDAQ), 26.56%
TDH Holdings, Inc. (PETZ:NASDAQ), 25.77%
VYNE Therapeutics Inc. (VYNE:NASDAQ), 25.28%
VCI Global Limited (VCIG:NASDAQ), 24.74%